🧠
33%
AI & Machine Learning
Intelligent systems that augment human cognition, automate diagnostics, and personalize wellness pathways at scale.
MVP Catalyst Fund 1 — Now Open
Investing in the
Evolution of Humanity
We fund breakthrough innovations in AI, biotechnology, and integrative health — backing visionary founders who are building the infrastructure of human flourishing.
Our Thesis
Strategic Capital at the
Frontier of Human Potential
We believe the most valuable companies of our time will not simply treat illness — they will unlock human flourishing mentally, physically, socially, and spiritually.
Our investment philosophy sits at the convergence of artificial intelligence, biotechnology, and human performance. We target breakthrough innovations that transcend traditional healthcare, creating intelligent, integrative, and personalized solutions that scale vitality.
We view human potential as the most undervalued asset class of the 21st century. Just as past industrial revolutions unlocked physical productivity, this era demands a revolution in mental, emotional, and biological performance.
$8M
Target Fund Size
$200K
Capital Raised
2028
Investment Horizon
25x
Target Return Multiple
MVP Catalyst Fund 1
A High-Conviction Vehicle for
Foundational Technologies
Our first fund identifies and empowers companies building foundational technologies for human flourishing — with strategic alignment, operational partnership, and long-term capital.
⚡
30%
Human Optimization
Technologies and protocols that elevate cognitive capacity, emotional resilience, and neurobiological performance.
🧬
24%
Biotechnology
Regenerative medicine, genomics platforms, and longevity science pushing the boundaries of biological capability.
🌿
13%
Alternative Medicine
Integrative therapies, psychedelic-assisted healing, and functional health platforms bridging ancient wisdom with modern science.
Sectors of Opportunity
Where Science Meets
Meaningful Outcomes
Positioned at the inflection point of a generational shift in how individuals, institutions, and governments approach health, intelligence, and performance.
01
Neuro-Enhancement & Cognitive Performance
Tools that expand mental bandwidth, accelerate learning, and sustain peak cognition
98
02
AI × Mental Health
Platforms merging artificial intelligence with clinical insight for accessible, precision therapy
94
03
Integrative & Functional Health
Bridging evidence-based medicine with holistic modalities for whole-person wellness
85
04
Biotech & Regenerative Medicine
Gene therapies, stem cell platforms, and longevity science redefining biological limits
82
05
Spiritual & Social Infrastructure
Community platforms, group healing systems, and connection-driven wellness architecture
77
The Market
A Generational
Inflection Point
We stand at the convergence of scientific maturity, cultural readiness, and exponential technology. Regulatory tailwinds — FDA pathways for psychedelic therapies, AI-assisted diagnostics, and decentralized clinical trials — are accelerating deal flow across our thesis.
Institutional appetite for impact-aligned returns is surging. The global wellness economy exceeds $5.6 trillion. Mental health technology alone represents a $15B+ market growing at 20%+ CAGR. Longevity biotech has attracted $6.5B+ in venture funding since 2020.
This isn't a trend — it's a structural shift. And Mosaic is positioned at the nexus of the forces driving it.
Regulatory Catalysts
FDA breakthrough designations for psychedelic therapies, AI-diagnostic approvals, and expanded telehealth access creating new market categories.
Cultural Readiness
Gen Z and Millennial demand for holistic wellness, plus post-COVID mental health awareness, reshaping consumer behavior at scale.
Technology Convergence
AI, genomics, wearables, and digital therapeutics maturing simultaneously — creating unprecedented compound innovation.
LP Appetite for Impact
Institutional investors increasingly seek thesis-driven funds delivering both outsized returns and measurable societal benefit.
Leadership
The Minds Behind
the Mission
Operators, builders, and investors united by the conviction that funding human potential is the highest-leverage investment of our era.
JM
Founder & Managing Partner
Jared Muenks
CEO, Mosaic Venture Partners
Architect of the Freestyle Systems Method™ and creator of the Business Systems Engineering Playbook. Over a decade advising and scaling mission-driven businesses through frameworks that align people, technology, and capital.
BS
Investor & Board Member
Brent Sobol
Philanthropist · Founder, Legacy Community Housing Corp.
Three decades in multifamily housing and community revitalization. Recognized by the Atlanta Housing Authority for civic leadership. Investment perspective grounded in operational rigor and systems thinking.
DK
Investor & Board Member
Demitra Kontras
Strategic Advisor & Impact Investor
A seasoned investor and strategic advisor bringing cross-sector expertise to the Mosaic portfolio, with a focus on bridging innovation with enduring value creation.
“
Legacy Community Engagement Corporation is proud to make a catalytic seed investment in MVP Catalyst Fund 1. As a charitable foundation, we are committed to identifying visionary leaders advancing technologies that enable meaningful human breakthroughs.
Brent Sobol
International Angel Investor · Philanthropist
Open for Investment
Experience a True
Financial Breakthrough
MVP Catalyst Fund 1 is actively deploying capital. Whether you're an accredited investor seeking exposure to frontier human-potential technologies, or a visionary founder building in our thesis areas — we want to hear from you.
For accredited investors only. Investment involves risk including potential loss of principal.